Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 742-uterine-and-adnexa-procedures-for-non-malignancy-with-cc-mcc
    Ask Trek AI about this page

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    DRG 742 addresses inpatient uterine and adnexa procedures for non-malignant conditions when Major Complication or Comorbidity or Complication or Comorbidity are present, covering surgeries such as hysterectomy and adnexal operations with added clinical complexity. Correct assignment of this Diagnosis-Related Group matters for inpatient reimbursement because the presence of additional complications or comorbidities increases expected resource use and influences Centers for Medicare & Medicaid Services payment classification.

    Customize your policy alerts

    Sign up for drg 742 policy alerts

    Get alerted when payer policies referencing 742 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 742 Overview

    DRG 742 covers inpatient admissions for uterine and adnexa procedures performed for non-malignant conditions when a patient has at least one Major Complication or Comorbidity or Complication or Comorbidity. This Diagnosis-Related Group encompasses common gynecologic surgeries such as hysterectomy, oophorectomy, and adnexal procedures when complicated by additional clinical conditions that increase resource use. It matters for Medicare payment because the presence of Major Complication or Comorbidity or Complication or Comorbidity affects reimbursement relative to lower-severity groups, reflecting higher expected hospital resource consumption. Accurate coding of diagnoses and procedures determines appropriate inpatient reimbursement under Centers for Medicare & Medicaid Services payment policies.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative optimization and enhanced recovery protocol trials assessing strategies to reduce length of stay and postoperative complications after non-malignant uterine and adnexal surgeries with CC/MCC. These studies enroll patients admitted for hysterectomy, myomectomy, ovarian cystectomy, or adnexal surgery who present with comorbid conditions (eg, anemia, diabetes, obesity, congestive heart failure) that qualify as CC/MCC, and compare care bundles such as preoperative risk stratification, multimodal analgesia, thromboprophylaxis, and early mobilization. Findings are directly relevant to providers aiming to decrease surgical morbidity and to payers seeking reduced resource utilization and readmissions in this high-acuity surgical DRG.
    • Comparative effectiveness trials evaluating surgical approaches and intraoperative technologies for complex benign uterine and adnexal disease in patients with comorbidities. These trials compare outcomes between minimally invasive (laparoscopic/robotic) versus open or vaginal procedures, or evaluate blood conservation techniques and hemostatic adjuncts in patients with significant comorbid conditions or CC/MCC-level severity. Results inform procedure selection, perioperative risk management, and coding/resource allocation decisions that impact reimbursement and length-of-stay for cases grouped to DRG 742.
    • Post-discharge outcomes and health services research studying readmission drivers, complication surveillance, and cost-effectiveness of follow-up care models for patients discharged after non-malignant uterine and adnexal procedures with CC/MCC. Such observational cohort studies or pragmatic trials focus on high-risk subgroups (eg, patients with chronic cardiopulmonary disease, renal insufficiency, or complex social needs) to identify predictors of unplanned returns, optimize discharge planning, and evaluate outpatient care pathways or telemonitoring. This evidence helps hospitals and payers target interventions to reduce costly readmissions and improve quality metrics tied to reimbursement for this DRG.

    Related Codes

    734-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITH-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    738-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    740-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    741-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    744-D-C-CONIZATION-LAPAROSCOPY-AND-TUBAL-INTERRUPTION-WITH-CC-MCC

    D&C, Conization, Laparoscopy and Tubal Interruption with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.